Register Now for The Outlook on Active Nutrition
News|Articles|April 21, 2026

Nektium to Showcase Zynamite and Rhodiolife Energy Concepts at Vitafoods 2026, Backed by Clinical Research

Author(s)Erin McEvoy
Listen
0:00 / 0:00

Key Takeaways

  • Product concepts emphasize low-stimulant energy, showcasing Zynamite-based RTDs, Rhodiolife-infused coffees, and capsule delivery for Vanizem to improve consumer-friendly adoption and manufacturing scalability.
  • Mechanistic positioning for Zynamite centers on mangiferin-associated antioxidant and anti-inflammatory bioactivity, supporting claims around cognitive resilience, mental clarity, and fast-onset focus without caffeine-linked side effects.
SHOW MORE

Nektium will showcase energy beverage concepts, featuring Zynamite RTDs and Rhodiolife-infused coffees at the event.

Nektium is reinforcing the scientific and commercial positioning of its portfolio as a next-generation energy solution, combining new clinical insights with innovative delivery formats set to be showcased at Vitafoods Europe 2026, an April news release from the company explains.1 At the Barcelona event, the company will highlight a range of ready-to-drink (RTD) and functional beverage concepts, including Zynamite-based energy drinks and Rhodiolife-infused coffees, demonstrating how clinically supported botanicals can be translated into scalable, consumer-friendly formats. It will also showcase Vanizem, an extract for stress and sleep.

“Modern consumers are looking for proven natural solutions that deliver benefits they can truly feel,” stated Bruno Berheide, Nektium’s Commercial and Partnership Director. “Our botanical portfolio unlocks new possibilities for the industry by pairing exceptional natural ingredients with cutting-edge formulation possibilities.”

The showcase highlights non-caffeinated or low-stimulant energy solutions, plus the research conducted on the extracts.

Zynamite, a Caffeine Alternative

Water-soluble Zynamite, a standardized mango leaf extract, is positioned as a fast-acting, side-effect-free alternative to caffeine, with demonstrated benefits in mental clarity, focus, and cognitive performance.

This positioning is supported by a growing body of research, including recent publications examining the ingredient’s bioactive profile and physiological effects. A case study published in Functional Foods in Health and Disease in 2026 provides detailed characterization of mango leaf extract, identifying bioactive compounds—including the primary compound mangiferin—that contribute to antioxidant and anti-inflammatory activity.2 These mechanisms are recognized as impacting the central nervous system and influencing cognitive resilience. The study frames Zynamite as a natural nootropic with translational relevance, bridging traditional botanical use with modern clinical validation, highlighting improvements in attention, reaction time, and mental energy.

Rhodiolife for Enhanced Athletic Performance

Beyond Zynamite, Nektium is also spotlighting Rhodiolife, its standardized Rhodiola rosea extract, which has demonstrated benefits in mental energy, stress resilience, and physical performance. Recent findings suggest that combining Rhodiola with caffeine may enhance both explosive power and sustained athletic output, reinforcing its relevance for active nutrition applications. Published in Metabolites in 2025, the research involved 96 trained and untrained participants in a standard boxing training program, with one group given Rhodiolife, a second group given caffeine, a third group given a combination of caffeine and Rhodiolife, a third group given the placebo. 3 The performance of the Rhodiolife group compared with the others suggested a potential improvement in energy metabolism efficiency and neuromuscular coordination, the study noted.

Vanizem for Stress and Sleep

Nektium’s Aframomum melegueta (Grains of Paradise) extract Vanizem will also be highlighted, available in capsule format. Vanizem is positioned as easing stress and enhancing sleep and mood in a low dose by acting on anandamide, called the “bliss molecule.” A clinical trial published in Pharmaceuticals in 2025 found that after three days of daily supplementation of Vanizem, participants reported reductions in anxiety and tension, and improvements in mood and sleep quality.4

In addition to its clinically substantiated botanicals, the company noted its vertically integrated supply chains and delivery technologies. “Nektium always goes the extra mile to deliver botanicals that customers and consumers alike can truly believe in,” Miguel Jiménez, President and CEO stated. “From gold-standard studies to quality testing to innovative delivery technologies, we take pride in providing ingredients that set manufacturers up for success.” The company will present Nektium Talks at its booth at Vitafoods to explain how its technologies support the efficacy, stability, and formulation versatility.

This article was created with assistance from AI. The content has been reviewed and edited by Erin McEvoy, Associate Editor. For more information on the extent and nature of AI usage, please contact us.

References

  1. Nektium. Next-gen energy: Nektium to present Rhodiolife® coffees and Zynamite® RTDs at Vitafoods 2026. April 8, 2026. Accessed April 21, 2026. https://nektium.prezly.com/next-gen-energy-nektium-to-present-rhodiolifer-coffees-and-zynamiter-rtds-at-vitafoods-2026
  2. Beltrán-Arranz A, Fuentes-Ríos D, Pérez-Machín R, López-Ríos L. A natural nootropic for cognitive enhancement: A case study on the standardized mango leaf extract Zynamite®. Functional Foods in Health and Disease 2026;16(2):118–131. doi: 10.31989/ffhd.v16i2.1855
  3. Tao B, Sun H, Li H, Xu Z, Xu Y, Chen L, et al. Combined effects of Rhodiola rosea and caffeine supplementation on straight punch explosive power in untrained and trained boxing volunteers: a synergistic approach. Metabolites. 2025;15(4):262. doi:10.3390/metabo15040262
  4. Pérez-Machín R, Vega-Morales T, Elvira-Aranda C, Lledó-Rico L, Gomis-Gomis MJ, López-Ríos L. Aframomum melegueta seed extract’s effects on anxiety, stress, mood, and sleep: a randomized, double-blind, pilot clinical trial. Pharmaceuticals. 2025;18(2):278. doi:10.3390/ph18020278